In this Section |
4289.0 Translational research on chronic disease in API populationsTuesday, October 30, 2012: 2:30 PM - 4:00 PM
Oral
Asian and Pacific Islander (API) populations experience a significant chronic disease burden, particularly with regard to diet-related diseases. The NIH-funded randomized, controlled trial, Diabetes Prevention Program, reported a 58% reduction in risk of developing type 2 diabetes through intensive lifestyle intervention among participants who were overweight and had prediabetes. National and local efforts are underway to translate this trial to underserved, ethnic minority populations who are disproportionately affected. This session will present some of the field’s newest approaches to translating this trial, and highlight the unique considerations and challenges when working to prevent chronic disease in diverse API populations. Lessons learned can also inform the translation of controlled trials in other non-API ethnic minority populations.
Session Objectives: At the end of the session, participants will be able to: 1) Describe perceptions of the cause and treatments for diabetes and experiences of inequities in treatment among the Hmong, Cambodian, Lao and Khmu communities; 2) Discuss the process used to translate the Diabetes Prevention Program lifestyle intervention to Native Hawaiian and Pacific Islander communities; 3) Discuss how to implement a Community Health Worker intervention translated for diabetic Bangladeshis in New York City; and 4) Discuss the design of the Pacific Islander Women's Health Spa, a culture- specific obesity prevention workshop.
Moderator:
Aimee Afable-Munsuz, PhD, MPH
2:30pm
2:45pm
3:00pm
See individual abstracts for presenting author's disclosure statement and author's information. Organized by: Asian Pacific Islander Caucus for Public Health
CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH) , Masters Certified Health Education Specialist (MCHES)
See more of: Asian Pacific Islander Caucus for Public Health
|